Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) ...

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

However, compounded drugs do not go through the same quality, effectiveness, and safety checks as drugs approved by the Food and Drug Administration (FDA). Compounded semaglutide and Ozempic ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

Today CMS announced that payments to Medicare Advantage and Part D Prescription Plans would increase by 5.06% next year ...

Biopharma leaders react to the forced resignation of CBER Head Peter Marks as RFK Jr.’s promised job cuts begin at the FDA; ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.